Impact of mental disorders on adherence to therapy in patients with atrial fibrillation

Volel’ B.A.; Troshina D.V.; Fomicheva A.V.; Gogniyeva D.G.; Bogdanova R.S.; Kopylov F.Yu.; Syrkina E.A.

doi:https://doi.org/10.17116/kardio202013061530

Close metadata

Recommended articles:

Left atrial reduction in mitral valve surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):460-470

Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37

Atrial fibrillation recurrences after catheter treatment and laboratory markers: is there a correlation?. Russian Journal of Preventive Medicine. 2025;(7):56-62

Validation of the Snaith—Hamilton Pleasure Scale to assess anhedonia in patients with unipolar depression In Russia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):110-121

Psycho-emotional state and self-reported sleep quality in students with bimodality of the ability to be active in the morning and evening in the sleep—wake cycle. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):130-134

Factors supporting chronic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15

Psychodermatological aspects of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):403-411

Adherence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):483-488

Visceral obesity is a reversible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16

Features of depressive disorders and suicidal behavior in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):7-13

Abstract:

Atrial fibrillation (AF) is one of the most common chronic cardiac diseases. Therapy of AF implies continuous medication and other medical recommendations. Adherence to therapy is considered among the main factors influencing the effectiveness of therapy. This review is devoted to the impact of mental disorders, cognitive impairment, and personality patterns on adherence to therapy in patients with AF.

Keywords:

atrial fibrillation

adherence to therapy

anxiety

depression

Authors:

Volel’ B.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Mental Health Research Center

ORCID: 0000-0003-1667-5355

Troshina D.V.

Sechenov First Moscow State Medical University

Fomicheva A.V.

Mental Health Research Center

Gogniyeva D.G.

The first Moscow State Medical University named after I.M. Sechenov (Sechenov University)

Bogdanova R.S.

Sechenov First Moscow State Medical University

Kopylov F.Yu.

Sechenov First Moscow State Medical University

Scopus AuthorID: 6507736224
ORCID: 0000-0001-5124-6383

Syrkina E.A.

The first Moscow State Medical University named after I.M. Sechenov (Sechenov University)

Received:

19.06.2020

Accepted:

20.07.2020

Close metadata

References:

Bockeria LA, Polunina AG, Lefterova NF, et al. Atrium fibrillation and enlargement of left heart chambers: pathological mechanisms of cognitive dysfunction in cardiologic patients. Russ Kreativnaya kardiologiya. 2015;9(1):38-45. (In Russ.). https://doi.org/10.15275/kreatkard.2015.01.04
Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119
Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014;6:213. https://doi.org/10.2147/CLEP.S47385
Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circulation research. 2017;120(9):1501-1517. https://doi.org/10.1161/CIRCRESAHA.117.309732
Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. 2016;352:h7013. https://doi.org/10.1136/bmj.h7013
Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447-454. https://doi.org/10.1161/CIR.000.000.0000000366
Steinberg BA, Piccini JP. Anticoagulation in atrial fibrillation. Bmj. 2014;348:g2116. https://doi.org/10.1136/bmj.g2116
Prystowsky EN, Padanilam BJ, Fogel RI. Treatment of atrial fibrillation. Jama. 2015;314(3):278-288. https://doi.org/10.1001/jama.2015.7505
World Health Organisation. Adherence to long-term therapies, evidence for action. 2003. https://www.who.int/chp/knowledge/publications/adherence_report/en
Gorst‐Rasmussen A, Skjøth F, Larsen TB, et al. Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. Journal of Thrombosis and Haemostasis. 2015;13(4):495-504. https://doi.org/10.1111/jth.12845
Abdou JK, Auyeung V, Patel JP, et al. Adherence to long‐term anticoagulation treatment, what is known and what the future might hold. British journal of haematology. 2016;174(1):30-42. https://doi.org/10.1111/bjh.14134
Deitelzweig SB, Buysman E, Pinsky B, et al. Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population. Clinical therapeutics. 2013;35(8):1201-1210. https://doi.org/10.1016/j.clinthera.2013.06.005
Petrova NN, Kucher E.O. Treatment side effects and compliance in patients with depression. Russ Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2012;112(11):77-85. (In Russ.).
Jankowska-Polańska B, Katarzyna L, Lidia A, et al. Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation. Journal of geriatric cardiology: JGC. 2016;13(7):559. https://doi.org/10.11909/j.issn.1671-5411.2016.07.006
Wang W, Saczynski J, Lessard D, et al. Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE‐AF study. Journal of cardiovascular electrophysiology. 2019;30(11):2508-2515. https://doi.org/10.1111/jce.14176
Elezi S, Qerkini G, Bujupi L, et al. Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo-a single-center study. Anatolian Journal of Cardiology/Anadolu Kardiyoloji Dergisi. 2010;10(1). https://doi.org/10.5152/akd.2010.008
LaMori JC, Mody SH, Gross HJ, et al. Burden of comorbidities among patients with atrial fibrillation. Therapeutic advances in cardiovascular disease. 2013;7(2):53-62. https://doi.org/10.1177/175.394.4712464101
Søgaard M, Skjøth F, Kjældgaard JN, et al. Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study. BMJ open. 2017;7(12):e018209. https://doi.org/10.1136/bmjopen-2017-018209
Chou RH, Lo LW, Liou YJ, et al. Antipsychotic treatment is associated with risk of atrial fibrillation: a nationwide nested case-control study. International journal of cardiology. 2017;227:134-140. https://doi.org/1016/j.ijcard.2016.11.185
Yakovenko TV, Shubik YuV, Kostyuk GP et al. Structure and dynamics of nosogenic psychical reactions in patients with different types of atrial fibrillation. Russ Vestnik aritmologii. 2006;44:26-29. (In Russ.).
Patel D, Mc Conkey ND, Sohaney R, et al. A systematic review of depression and anxiety in patients with atrial fibrillation: the mind-heart link. Cardiovascular psychiatry and neurology. 2013. https://doi.org/10.1155/2013/159850
Kopilov FYu. Psihosomaticheskie aspekty serdechno-sosudistyh zabolevanij (gipertonicheskoj bolezni, ishemicheskoj bolezni serdca, fibrillyacii predserdij). M. 2008. (In Russ.).
McCabe PJ. Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. Journal of Cardiovascular Nursing. 2010;25(1):40-51. https://doi.org/10.1097/JCN.0b013e3181b7be36
von Eisenhart Rothe AF, Goette A, Kirchhof P, et al. Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. Europace. 2014;16(6):812-819. https://doi.org/10.1093/europace/eut361
Polikandrioti M, Koutelekos I, Vasilopoulos G, et al. Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors. Cardiology research and practice. 2018. https://doi.org/10.1155/2018/7408129
Pozuelo L. Fine-tuning a heart-brain connection: anxiety in atrial fibrillation. 2012;5:307-308. https://doi.org/10.1161/CIRCHEARTFAILURE.112.967778
Galli F, Borghi L, Carugo S, et al. Atrial fibrillation and psychological factors: a systematic review. Peer J. 2017;5:e3537. https://doi.org/10.7717/peerj.3537
Baumgartner C, Fan D, Fang MC, et al. Anxiety, depression, and adverse clinical outcomes in patients with atrial fibrillation starting warfarin: cardiovascular research network WAVE study. Journal of the American Heart Association. 2018;7(8):e007814. https://doi.org/10.1161/JAHA.117.007814
Gehi AK, Sears S, Goli N, et al. Psychopathology and symptoms of atrial fibrillation: implications for therapy. Journal of Cardiovascular Electrophysiology. 2012;23(5):473-478. https://doi.org/10.1111/j.1540-8167.2011.02264.x
Kupper N, Broek KVD, Widdershoven J, et al. Subjectively reported symptoms in patients with persistent atrial fibrillation and emotional distress. Frontiers in psychology. 2013;4:192. https://doi.org/10.3389/fpsyg.2013.00192
Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. Journal of Psychosomatic Research. 2007;63(5):509-513. https://doi.org/1016/j.jpsychores.2007.07.010
Frasure-Smith N., Lespérance F, Irwin MR, et al. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain, behavior, and immunity. 2009;23(8):1140-1147. https://doi.org/10.1016/j.bbi.2009.07.005
Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. Journal of the American College of Cardiology. 2007;50(21):2021-2028. https://doi.org/10.1016/j.jacc.2007.06.054
Matskevich SA, Barbuk OA, Belskaya MI, et al. Psycho-emotional changes in patients with chronic heart failure. Evrazijskij kardiologicheskij zhurnal. 2016;(1):24-27. (In Russ.).
Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. Journal of psychosomatic research. 2002;53(4):873-876. https://doi.org/10.1016/S0022-3999(02)00309-4
Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2011;57(2):223-242. https://doi.org/10.1016/j.jacc.2010.10.001
Santangeli P, Di Biase L, Bai R, et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm. 2012;9(11):1761-1768. https://doi.org/10.1016/j.hrthm.2012.07.026
Thacker EL, McKnight B, Psaty BM, et al. Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology. 2013;81(2):119-125. https://doi.org/10.1212/WNL.0b013e31829a33d1
Rydén L, Zettergren A, Seidu NM, et al. Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke. Journal of internal medicine. 2019;286(1):101-110. https://doi.org/10.1111/joim.12902
Myserlis PG, Malli A, Kalaitzoglou DK, et al. Atrial fibrillation and cognitive function in patients with heart failure: a systematic review and meta-analysis. Heart failure reviews. 2017;22(1):1-11. https://doi.org/10.1007/s10741.016.9587-y
Calderón-Larrañaga A, Diaz E, Poblador-Plou B, et al. Non-adherence to antihypertensive medication: the role of mental and physical comorbidity. International journal of cardiology. 2016;207:310-316. https://doi.org/10.1016/j.ijcard.2016.01.069
Dempe C, Jünger J, Hoppe S, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. Journal of psychosomatic research. 2013;74(2):122-127. https://doi.org/10.1016/j.jpsychores.2012.12.003
Boima V, Ademola AD, Odusola AO, et al. Factors associated with medication nonadherence among hypertensives in Ghana and Nigeria. International journal of hypertension. 2015. https://doi.org/10.1155/2015/205716.
Suzuki T, Shiga T, Omori H, et al. Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. Journal of cardiology. 2017;70(3):238-243. https://doi.org/10.1016/j.jjcc.2016.11.009
Reading SR, Black MH, Singer DE, et al. Risk factors for medication non-adherence among atrial fibrillation patients. BMC cardiovascular disorders. 2019;19(1):38. https://doi.org/10.1186/s12872.019.1019-1
Emren SV, Şenöz O, Bilgin M, et al. Drug adherence in patients with nonvalvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey: NOAC-TR. Clinical and Applied Thrombosis/Hemostasis. 2018;24(3):525-531. https://doi.org/10.1177/107.602.9617693940
Fenger-Grøn M, Vestergaard CH, Frost L, et al. Depression and Uptake of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation: A Danish Nationwide Cohort Study. Medical care. 2020;58(3):216-224. https://doi.org/10.1097/MLR.000.000.0000001268
Ferguson C, Inglis SC, Newton PJ, et al. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives. Journal of clinical nursing. 2017;26(23-24):4325-4334. https://doi.org/10.1111/jocn.13759
Saczynski JS, Sanghai SR, Kiefe CI, et al. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE‐AF. Journal of the American Geriatrics Society. 2020;68.1:147-154. https://doi.org/10.1111/jgs.16178
Taylor EC, O’Neill M, Hughes LD, et al. Examining Adherence to Medication in Patients With Atrial Fibrillation: The Role of Medication Beliefs, Attitudes, and Depression. Journal of Cardiovascular Nursing. 2020. https://doi.org/10.1097/JCN.000.000.0000000650
McGrady A, McGinnis R, Badenhop D, et al. Effects of depression and anxiety on adherence to cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. 2009;29(6):358-364. https://doi.org/10.1097/HCR.0b013e3181be7a8f
Miyazaki M, Nakashima A, Nakamura Y, et al. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: an observational cross-sectional pilot study. PloS one. 2018;13(9):e0204814. https://doi.org/10.1371/journal.pone.0204814
Troshina D.V. Psihicheskie rasstrojstva u bol’nyh fibrillyaciej predserdij. First Medical University First Moscow Medical University I.M. Sechenova (Sechenov University). 2009. (In Russ.).
Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? Journal of Thrombosis and Haemostasis. 2008;6(9):1500-1506. https://doi.org/10.1111/j.1538-7836.2008.03059.x
Bauer LK, Caro MA, Beach SR, et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. The American journal of cardiology. 2012;109(9):1266-1271. https://doi.org/10.1016/j.amjcard.2011.12.017
Rodriguez-Bernal CL, Peiró S, Hurtado I, et al. Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: real-world data from a population-based cohort. Journal of managed care & specialty pharmacy. 2018;24(5):440-448. https://doi.org/10.18553/jmcp.2018.24.5.440
Pandya EY, Bajorek B. Factors affecting patients’ perception on, and adherence to, anticoagulant therapy: anticipating the role of direct oral anticoagulants. The Patient-Patient-Centered Outcomes Research. 2017;10(2):163-185. https://doi.org/10.1007/s40271.016.0180-1
Kim JH, Kim GS, Kim EJ, et al. Factors affecting medication adherence and anticoagulation control in Korean patients taking warfarin. Journal of Cardiovascular Nursing. 2011;26(6):466-474. https://doi.org/10.1097/JCN.0b013e31820914e7
Dunbar F. Psychosomatic diagnosis. New York: Hoeber; 1943.
Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings: blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. Journal of the American Medical Association. 1959;169(12):1286-1296. https://doi.org/10.1001/jama.1959.030.00290012005
Mols F, Denollet J. Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health and quality of life outcomes. 2010;8(1):9. https://doi.org/10.1186/1477-7525-8-9
Hart RP, Barth JT, Ball JD, et al. Correlations for Scores on the 180-Item Version of the MMPI—2 and the Neuroticism Scale of the Neo-Personality Inventory. Psychological reports. 2002;90(1):227-230. https://doi.org/10.2466/pr0.2002.90.1.227
Mattioli AV, Bonatti S, Zennaro M, et al. The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. EP Europace. 2005;7(3):211-220. https://doi.org/10.1016/j.eupc.2004.02.006
Eaker ED, Sullivan LM, Kelly-Hayes M, et al. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation. 2004;109(10):1267-1271. https://doi.org/10.1161/01.CIR.000.011.8535.15205.8F
Lukashenko AA, Yurovskaya II, Artem’ieva MS. The role of emotional in the genesis of life-threatening heart rhythm disorders. 2014;2:35-41. (In Russ.).
Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review. The American journal of medicine. 2006;119(5):448-e1. https://doi.org/10.1016/j.amjmed.2005.10.057
Pilowsky I. Abnormal illness behaviour (dysnosognosia). Psychotherapy and psychosomatics. 1986;46(1-2):76-84.
Alekhin AN, Trifonova EA, Lebedev DS, et al. Psychological problems in arrhythmology (on a model of atrial fibrillation). Vestnik aritmologii. 2011;63:45-54. (In Russ.).
Streur M, Ratcliffe SJ, Callans D, et al. Atrial fibrillation symptom clusters and associated clinical characteristics and outcomes: A cross-sectional secondary data analysis. European Journal of Cardiovascular Nursing. 2018;17(8):707-716. https://doi.org/10.1177/147.451.5118778445
Volel BA, Troshina DV, Grubova MV, et al. Psychiatric (personality) disorders in patients with atrial fibrillation. Psihicheskie rasstrojstva v obshchej medicine. 2016;1-2:27-35 (In Russ.).
Quirk SE, El-Gabalawy R, Brennan SL, et al. Personality disorders and physical comorbidities in adults from the United States: data from the National Epidemiologic Survey on Alcohol and Related Conditions. Social psychiatry and psychiatric epidemiology. 2015;50(5):807-820. https://doi.org/10.1007/s00127.014.0974-1
Wu JR, Moser DK. Type D personality predicts poor medication adherence in patients with heart failure in the USA. International journal of behavioral medicine. 2014;21(5):833-842. https://doi.org/10.1007/s12529.013.9366-2
Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:49-73. https://doi.org/10.1161/01.cir.000.043.7741.48606.98
Cruess DG, Localio AR, Platt AB, et al. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. International journal of behavioral medicine. 2010;17(1):33-42. https://doi.org/10.1007/s12529.009.9052-6